Pediatric pseudotumor cerebri

Brita S Rook1, Paul H Phillips

  • 1Department of Ophthalmology, Arkansas Children's Hospital, University of Arkansas for Medical Sciences, Jones Eye Institute, Little Rock, Arkansas, USA.

Insights

Pediatric pseudotumor cerebri (PTC) diagnosis and treatment differ from adults. Revised criteria and risk factors like obesity are key, with Diamox and weight loss showing effectiveness for mild cases.

Area of Science:

  • Neurology
  • Ophthalmology
  • Pediatrics

Background:

  • Pseudotumor cerebri (PTC) in children requires tailored management distinct from adults.
  • Literature review highlights evolving understanding of pediatric PTC.

Purpose of the Study:

  • To review recent findings on pediatric pseudotumor cerebri (PTC) epidemiology, diagnosis, and treatment.
  • To emphasize differences between pediatric and adult PTC cases.

Main Methods:

  • Literature review of recent studies on pediatric PTC.
  • Analysis of diagnostic criteria, risk factors, imaging, and treatment outcomes.

Main Results:

  • Revised diagnostic criteria: elevated cerebrospinal fluid pressure >28 cm H2O in children.
  • Obesity is a significant risk factor in post-pubertal children.
  • MRI findings suggestive of elevated intracranial pressure are similar to adults.
  • Diamox and weight loss are effective for mild visual field loss.
  • Severe papilledema and decreased vision predict higher risk of visual loss.

Conclusions:

  • Recent findings may alter current pediatric PTC diagnosis and treatment practices.
  • Pediatric PTC management should consider specific differences compared to adults.
Abstract